Common new active substance approvals across major regulatory authorities (multi-year total) vs Novel active substance launches
Common new active substance approvals across major regulatory authorities (multi-year total) and Novel active substance launches worldwide, compared over time.
Change the pair
Compare different indicators
The series
Over time
Global, spaced by time. Both series are in count, so they share one axis; the legend names each line.
Common new active substance approvals across major regulatory authorities (multi-year total) and Novel active substance launches
Unit: count · 4 observations
View the underlying data
| Indicator | Period | Type | Value |
|---|---|---|---|
| Common new active substance approvals across major regulatory authorities (multi-year total) | 2021–2025 | Actual | 52 |
| Common new active substance approvals across major regulatory authorities (multi-year total) | 2016–2020 | Actual | 37 |
| Novel active substance launches | 2025 | Actual | 79 |
| Novel active substance launches | 2004–2023 | Actual | 942 |
Source: CIRS, IFPMA, IQVIA · CC BY 4.0 · Common new active substance approvals across major regulatory authorities (multi-year total) · Novel active substance launches
Provenance
Where these numbers come from
Common new active substance approvals across major regulatory authorities (multi-year total)
Total count of new active substances approved across all designated major regulatory authorities during the period.
2 observations in Global · source organisations: CIRS
Novel active substance launches
Total number of novel active substances launched.
2 observations in Global · source organisations: IFPMA, IQVIA
Data published under CC BY 4.0. Series A as JSON · Series B as JSON
Keep exploring